Ambey Laboratories Balance Sheet Health
Financial Health criteria checks 4/6
Ambey Laboratories has a total shareholder equity of ₹236.4M and total debt of ₹136.5M, which brings its debt-to-equity ratio to 57.8%. Its total assets and total liabilities are ₹576.2M and ₹339.8M respectively. Ambey Laboratories's EBIT is ₹79.9M making its interest coverage ratio 4.4. It has cash and short-term investments of ₹10.2M.
Key information
57.8%
Debt to equity ratio
₹136.52m
Debt
Interest coverage ratio | 4.4x |
Cash | ₹10.15m |
Equity | ₹236.36m |
Total liabilities | ₹339.83m |
Total assets | ₹576.19m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMBEY's short term assets (₹276.3M) exceed its short term liabilities (₹202.8M).
Long Term Liabilities: AMBEY's short term assets (₹276.3M) exceed its long term liabilities (₹137.1M).
Debt to Equity History and Analysis
Debt Level: AMBEY's net debt to equity ratio (53.5%) is considered high.
Reducing Debt: Insufficient data to determine if AMBEY's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: AMBEY's debt is well covered by operating cash flow (69.2%).
Interest Coverage: AMBEY's interest payments on its debt are well covered by EBIT (4.4x coverage).